IGF1 and Hypoglycemia: However, IGF-1 treatment has significant potential adverse effects including hypoglycemia, lymphoid overgrowth, benign intracranial pressure, coarsening of facial features, and, similar to GH, a theoretical increased risk of malignancies (11–13).